Annual report pursuant to Section 13 and 15(d)

Note 2 - Acquisitions (Details Textual)

Note 2 - Acquisitions (Details Textual) $ in Thousands								3 Months Ended	6 Months Ended	9 Months Ended	11 Months Ended		12 Months Ended
Note 2 - Acquisitions (Details Textual) $ in Thousands	Aug. 01, 2016 USD ($)	Jul. 01, 2016 USD ($)	Mar. 14, 2016 USD ($)	Jul. 08, 2015 USD ($)	Nov. 03, 2014 USD ($)	Jul. 31, 2014 USD ($)	Jul. 02, 2014 USD ($)	Mar. 31, 2017 USD ($)	Jun. 30, 2017 USD ($)	Mar. 31, 2017 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability													$ (13,322)
Goodwill, Purchase Accounting Adjustments													1,809
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain															8,300
Payment for Contingent Consideration Liability, Financing Activities									$ 16,700				21,060
Business Combination, Contingent Consideration, Liability									68,400		$ 68,400	$ 68,400	68,400	38,500
Payments to Acquire Businesses, Net of Cash Acquired													$ 253,785	91,423	$ 420,102
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life													1 year
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life													20 years
Developed Technology Rights [Member]
Finite-Lived Intangible Asset, Useful Life													12 years
Developed Technology Rights [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life													9 years
Developed Technology Rights [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life													15 years
Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life													15 years
Trade Names [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life													5 years
Trade Names [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life													20 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life													10 years
Customer Relationships [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life													9 years
Customer Relationships [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life													16 years
Noncompete Agreements [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life													3 years
Noncompete Agreements [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life													5 years
Advanced Cell Diagnostics (ACD) [Member]
Goodwill, Purchase Accounting Adjustments											10,200	10,187
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Assets												(9,372)
Payments to Acquire Businesses, Gross	$ 258,000
Business Combination, Liabilities Arising from Contingencies, Amount Recognized	37,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	75,000								75,000		75,000	75,000	$ 75,000
Payments to Acquire Businesses, Net of Cash Acquired	246,193										$ 247,000		247,038
Business Combination, Consideration Transferred, Employee Vesting Period											1 year 180 days
Business Combination, Consideration Transferred, Liabilities Incurred											$ 11,000		3,600
Advanced Cell Diagnostics (ACD) [Member] \| Developed Technology Rights [Member]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles												43,000
Advanced Cell Diagnostics (ACD) [Member] \| Trade Names [Member]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles												4,900
Advanced Cell Diagnostics (ACD) [Member] \| Customer Relationships [Member]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles												(70,700)
Advanced Cell Diagnostics (ACD) [Member] \| Noncompete Agreements [Member]
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles												(200)
Advanced Cell Diagnostics (ACD) [Member] \| Pre-acquisition Services [Member]
Business Combination, Consideration Transferred, Liabilities Incurred											3,600
Advanced Cell Diagnostics (ACD) [Member] \| Future Services [Member]
Business Combination, Consideration Transferred, Liabilities Incurred											7,400
Advanced Cell Diagnostics (ACD) [Member] \| The 2016 Revenue Equal or Exceed $30 Milliom [Member]
Business Combination, Contingent Consideration, Liability	25,000
Business Combination, Contingent Consideration, Liability, Trigger Amount of Revenue	30,000
Advanced Cell Diagnostics (ACD) [Member] \| The 2017 Revenues Equal or Exceed $45 Million [Member]
Business Combination, Contingent Consideration, Liability	50,000
Business Combination, Contingent Consideration, Liability, Trigger Amount of Revenue	$ 45,000
Space [Member]
Payments to Acquire Businesses, Gross		$ 9,000
Payments to Acquire Businesses, Net of Cash Acquired		6,700											6,747
Business Combination, Consideration Transferred, Liabilities Incurred		$ 2,300											2,256
Zephyrus [Member]
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability										$ 3,000
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles										900
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets										$ 300
Goodwill, Purchase Accounting Adjustments														1,800
Payments to Acquire Businesses, Gross			$ 8,000
Business Combination, Liabilities Arising from Contingencies, Amount Recognized			6,500
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			7,000						7,000		7,000	7,000	7,000
Payment for Contingent Consideration Liability, Financing Activities								$ 3,500
Business Combination, Contingent Consideration, Liability			3,300
Payments to Acquire Businesses, Net of Cash Acquired													8,000
Business Combination, Consideration Transferred, Liabilities Incurred
Zephyrus [Member] \| Developed Technology Rights [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			7,400
Zephyrus [Member] \| Instruments Sales Contingency [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 3,500
Business Combination, Contingent Consideration, Liability, Number of Instruments Sold			10
Business Combination, Contingent Consideration, Liability, Anniversary of Closing Date			3 years
Business Combination, Contingent Consideration, Liability, Cumulative Sales			$ 3,000
Business Combination, Contingent Consideration, Liability, Number of Years Within Closing Date			4 years 182 days
Cliniqa [Member]
Payments to Acquire Businesses, Net of Cash Acquired				$ 82,900									82,888
Business Combination, Consideration Transferred, Liabilities Incurred
Cliniqa [Member] \| Developed Technology Rights [Member]
Finite-Lived Intangible Asset, Useful Life				14 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles				$ 18,000
Cliniqa [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life				13 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles				$ 27,000
Cliniqa [Member] \| Trademarks and Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life				4 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles				$ 1,100
CyVek, Inc. [Member]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures					$ 10,000
Noncontrolling Interest, Ownership Percentage by Parent					19.90%
Payments to Acquire Businesses, Gross					$ 62,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability					$ 35,000
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contingent Liability, Percentage					50.00%
Business Combination, Milestone Payment Threshold					$ 100,000
Business Combination, Liabilities Arising from Contingencies, Amount Recognized					35,000				35,000		35,000	35,000	35,000	$ 35,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain					$ 8,300
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High									$ 35,000		$ 35,000	$ 35,000	35,000
Payments to Acquire Businesses, Net of Cash Acquired													60,122
Business Combination, Consideration Transferred, Liabilities Incurred
CyVek, Inc. [Member] \| Developed Technology Rights [Member]
Finite-Lived Intangible Asset, Useful Life					15 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles					$ 20,200
CyVek, Inc. [Member] \| Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life					1 year 182 days
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles					$ 100
CyVek, Inc. [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life					10 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles					$ 600
ProteinSimple [Member]
Payments to Acquire Businesses, Net of Cash Acquired													300,053
Business Combination, Consideration Transferred, Liabilities Incurred
ProteinSimple [Member] \| Developed Technology Rights [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles						$ 39,200
ProteinSimple [Member] \| Developed Technology Rights [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life						9 years
ProteinSimple [Member] \| Developed Technology Rights [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life						10 years
ProteinSimple [Member] \| Trade Names [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles						$ 36,100
ProteinSimple [Member] \| Trade Names [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life						18 years
ProteinSimple [Member] \| Trade Names [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life						20 years
ProteinSimple [Member] \| Customer Relationships [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles						$ 101,600
ProteinSimple [Member] \| Customer Relationships [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life						14 years
ProteinSimple [Member] \| Customer Relationships [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life						16 years
ProteinSimple [Member] \| Noncompete Agreements [Member]
Finite-Lived Intangible Asset, Useful Life						3 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles						$ 200
Novus Holdings, LLC [Member]
Payments to Acquire Businesses, Net of Cash Acquired													59,927
Business Combination, Consideration Transferred, Liabilities Incurred
Novus Holdings, LLC [Member] \| Developed Technology Rights [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							$ 5,000
Novus Holdings, LLC [Member] \| Developed Technology Rights [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life							4 years
Novus Holdings, LLC [Member] \| Developed Technology Rights [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life							12 years
Novus Holdings, LLC [Member] \| Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life							20 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							$ 5,300
Novus Holdings, LLC [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life							15 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles							$ 14,400